Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

OBJECTIVE: The aim of this study was to evaluate the efficacy of maraviroc along with darunavir/ritonavir, all once daily, for the treatment of antiretroviral-naive HIV-1 infected individuals. DESIGN: MODERN was a multicentre, double-blind, noninferiority, phase III study in HIV-1 infected, antiretr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stellbrink, Hans-Jürgen, Le Fevre, Eric, Carr, Andrew, Saag, Michael S., Mukwaya, Geoffrey, Nozza, Silvia, Valluri, Srinivas Rao, Vourvahis, Manoli, Rinehart, Alex R., McFadyen, Lynn, Fichtenbaum, Carl, Clark, Andrew, Craig, Charles, Fang, Annie F., Heera, Jayvant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856180/
https://www.ncbi.nlm.nih.gov/pubmed/26854810
http://dx.doi.org/10.1097/QAD.0000000000001058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856180/
https://www.ncbi.nlm.nih.gov/pubmed/26854810
http://dx.doi.org/10.1097/QAD.0000000000001058

Ejemplares similares